Accuracy of Glucometer Testing for Gestational Diabetes - Health blog from Hyderabad Diabetes Centre

Authored by Theresa Vuskovich, DMD on November 28, 2022. Everlywell’s blog content is meticulously reviewed by medical and bioscience professionals to provide accurate and evidence-based information.

Content:

Key takeaways

Diabetes diagnosis through HbA1c and fasting plasma glucose (FPG) blood tests by healthcare providers.
HbA1c test measures blood sugar over 2 to 3 months, less affected by acute illness compared to FPG.
FPG test measures blood sugar after fasting, more responsive to acute conditions than HbA1c.

Diabetes, whether type 1, type 2, or prediabetes, arises from impaired insulin production and response in the body. HbA1c and FPG tests are employed to diagnose and monitor diabetes by measuring blood sugar levels. This article delves into these tests, highlighting their similarities and distinctions.

What is an HbA1c test?

The standardized HbA1c test evaluates blood glucose levels over the past 2 to 3 months and is unaffected by immediate changes, like recent illness or stress. It quantifies glycated hemoglobin (HbA1c) – red blood cells with sugar attachments.

Also known as A1C or hemoglobin A1C, it serves as a diagnostic tool for diabetes and related conditions. Healthcare providers may suggest an A1C test for individuals above 35 years or with specified risk factors.

Overweight or obesity (BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian Americans)
Family history of diabetes
Risk associated with race/ethnicity
Past heart disease record
Elevated blood pressure levels
Women affected by polycystic ovary syndrome
Lack of physical activity
Patients with prediabetes scheduled for annual testing
Pregnant women with gestational diabetes diagnosis
HIV diagnosis

An A1C test can be undertaken with your healthcare provider or at home, with results indicating diabetes status.

A confirmed diabetes diagnosis necessitates two positive tests from the same sample or a subsequent test. Normal outcomes suggest retesting every three years in the absence of symptoms.

Your healthcare provider will aid in interpreting your A1C results and assessing the risk of long-term complications.

Limited sensitivity
Variables affecting outcomes
Not validated in non-white populations
Importance of regular monitoring and management
Potential lifestyle changes to improve blood glucose levels
The significance of early detection and intervention in diabetes management

While A1C tests are common, they may not always accurately pinpoint diabetes. Healthcare providers often resort to the FPG test to validate a diagnosis.

When interpreting the results of a fasting plasma glucose test, it is important to note that a level between 100 and 125 mg/dL indicates prediabetes, which means that you are at a higher risk of developing diabetes in the future. It is essential to follow up with your healthcare provider for further testing and monitoring.
In addition to fasting plasma glucose tests, another commonly used test for monitoring blood sugar levels is the A1C test. This test measures the average blood sugar levels over the past 2-3 months and provides a different perspective on how well your blood sugar has been controlled.
While both tests are valuable in assessing your risk for diabetes and monitoring your blood sugar levels, they serve different purposes. The fasting plasma glucose test provides a snapshot of your blood sugar levels at a specific point in time, whereas the A1C test offers a broader view of your blood sugar control over a longer period.
It is important to work closely with your healthcare provider to interpret the results of these tests and develop a personalized plan for managing your blood sugar levels. By monitoring your blood sugar levels regularly and making healthy lifestyle choices, you can reduce your risk of developing diabetes and improve your overall health and well-being.

HbA1c vs. FPG: what are the similarities?

Both tests aid healthcare providers in grasping sugar metabolism and detecting diabetes through venous blood tests.

One key difference between HbA1c and FPG is the time frame they represent. HbA1c provides an average of blood sugar levels over the past 2-3 months, giving a more comprehensive picture of long-term glucose control. On the other hand, FPG measures blood sugar levels at a specific point in time, usually after an overnight fast, offering insight into immediate blood sugar levels.

Another important distinction is the accuracy of the tests. HbA1c is less influenced by daily fluctuations in blood sugar levels compared to FPG, making it a more reliable marker for overall glycemic control in individuals with diabetes.

It’s important to consult with your healthcare provider to determine which test is most suitable for your individual needs and circumstances. Regular monitoring of blood sugar levels, whether through HbA1c or FPG tests, is essential for managing diabetes effectively and preventing complications.

Gestational Diabetes Mellitus Overview

GDM poses health risks for pregnant women and infants, potentially leading to various complications. Nearly half of GDM-affected women develop type 2 diabetes post-delivery. Global GDM prevalence estimates fluctuate, with North America and Mexico reporting rates between 4.3% and 38.1%. The need for efficient GDM screening methods is stressed.

Current ADA guidelines recommend OGTT for GDM diagnosis. Mexico follows comparable criteria and endorses capillary blood glucose readings for GDM detection. IADPSG criteria suggest higher GDM prevalence than ADA guidelines. Prompt diagnosis and efficient screening are pivotal for improved outcomes in GDM cases.

It is important for healthcare providers to closely monitor pregnant women for signs of GDM and to provide appropriate education and support. Lifestyle changes, such as maintaining a healthy diet and engaging in regular physical activity, can help manage GDM and reduce the risk of complications for both the mother and baby. Regular prenatal care and monitoring blood glucose levels are essential for the management of GDM.

Main Findings

The study found that there was a strong correlation between glucometer values and standard OGTT results. The sensitivity of the glucometer in detecting GDM was 85%, with a specificity of 92%. The AUC analysis demonstrated good diagnostic precision for the glucometer compared to the OGTT.

Implications

These results suggest that using a glucometer for glucose monitoring in pregnant women could be a viable alternative to the standard OGTT. It provides a convenient and less invasive method for diagnosing GDM, especially in resource-limited settings where access to laboratory-based testing may be challenging.

Future Research

Further research is needed to validate the use of glucometers in diagnosing GDM in larger and more diverse populations. Longitudinal studies could also assess the effectiveness of glucometer monitoring in managing GDM and its impact on pregnancy outcomes.

In addition to the findings presented in the article, it is important to emphasize the importance of regular prenatal care for all pregnant women, including screening for gestational diabetes mellitus (GDM). Early detection and management of GDM can help reduce the risk of complications for both the mother and the baby.
It is crucial for healthcare providers to educate pregnant women about the risk factors for GDM, such as obesity, family history of diabetes, and previous history of GDM. Encouraging healthy lifestyle habits, such as maintaining a balanced diet and engaging in regular physical activity, can also play a significant role in preventing GDM.
Furthermore, ongoing research and advancements in technology, such as continuous glucose monitoring systems, may offer additional tools for monitoring and managing GDM. Collaborative efforts between healthcare providers, researchers, and policymakers are essential in improving the screening and management of GDM, particularly in resource-limited settings.
Overall, the integration of evidence-based practices, patient education, and access to appropriate healthcare resources are essential components in the comprehensive care of pregnant women at risk for GDM. By addressing GDM through a multidisciplinary approach, we can strive to improve the health outcomes for both mothers and babies.

Conclusion

The findings of this retrospective cohort analysis demonstrate the reliable sensitivity of capillary blood glucose testing. While plasma blood glucose testing is considered the gold standard for screening GDM, its widespread use may face challenges, particularly in low-resource settings where capillary blood glucose testing can be a viable alternative.

Data Sharing Statement

The complete deidentified dataset can be accessed in Supplementary Appendix 1. For the full study protocol, please contact the corresponding author.

Further data may be available upon request to the corresponding author. Please reach out through the contact information provided in the author affiliations section of this publication.

Ethics Approval and Informed Consent

Consent for Publication

All authors have given consent for the publication of this paper.

Acknowledgments

Author Contributions

All authors have significantly contributed to the reported work, including conception, study design, data acquisition, analysis, interpretation, drafting, revising, critically reviewing the article, final approval for publication, selecting the publishing journal, and overall accountability for the work.

Funding

The study was funded by Global Health Partnerships Eli Lilly and Company. The funder did not influence the study design, data collection, analysis, interpretation, report writing, or the decision to submit for publication. The study design was developed by the Carlos Slim Foundation, which also analyzed and interpreted the data and contributed to the report writing. The Ministry of Health Guanajuato, the Ministry of Health Hidalgo, and CIMIGEN were also involved in data collection.

Disclosure

HGR, JLG, LAMJ, AM, JOM, VGH, DAAH, RAD, and RMR are all employees of the Carlos Slim Foundation. The authors declare no other conflicts of interest related to this study.

References

1. American Diabetes Association Professional Practice Committee. Chapter 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–38. doi:10.2337/dc22-S002

2. International Diabetes Federation. Care & prevention; 2020. Available from: https://www. idf. org/our-activities/care-prevention/gdm. Accessed August 23 , 2022 .

3. International Diabetes Federation. Hyperglycaemia in pregnancy (Hip) (20–49 y): prevalence of gestational diabetes mellitus (GDM). Available from: https://diabetesatlas. org/data/en/indicators/14/. Accessed January 11 , 2022 .

4. International Diabetes Federation. Diabetes atlas 2021. 10th edition; 2021. Available from: https://diabetesatlas. org/atlas/tenth-edition/. Accessed August 20 , 2022 .

5. Centro Nacional de Equidad de Género y Salud Reproductiva. Diabetes y Embarazo: lineamiento técnico [Diabetes and Pregnancy: technical guidelines]. Ciudad de Mexico; 2017. Available from: http://cnegsr. salud. gob. mx/contenidos/descargas/SMP/LineamientoDiabetesyEmbarazo. pdf. Accessed January 11 , 2022 .

6. Reyes-Muñoz E, Parra A, Castillo-Mora A, Ortega-González C. Effect of the diagnostic criteria of the international association of diabetes and pregnancy study groups on the prevalence of gestational diabetes mellitus in urban Mexican women: a cross-sectional study. Endocr Pract. 2012;18(2):146–151. doi:10.4158/EP11167.OR

7. Huhn EA, Rossi SW, Hoesli I, Göbl CS. Controversies in screening and diagnostic criteria for gestational diabetes in early and late pregnancy. Front Endocrinol. 2018;9:696. doi:10.3389/fendo.2018.00696

8. Vince K, Perković P, Matijević R. What is known and what remains unresolved regarding gestational diabetes mellitus (GDM). J Perinat Med. 2020;48(8):757–763. doi:10.1515/jpm-2020-0254

9. Secretaria de Salud de Mexico. Algoritmos de atención clínica: embarazo [Clinical care algorithms: Pregnancy care]. Ciudad de Mexico; 2019. Available from: http://educads. salud. gob. mx/sitio/recursos/E…
A literature review conducted by Facchinetti F, Dante G, Petrella E, and Neri I in 2014 explored the role of dietary interventions, lifestyle changes, and dietary supplements in preventing gestational diabetes mellitus.
Other relevant studies include:
– A study by Tanentsapf I, Heitmann BL, and Adegboye AR in 2011 published in BMC Pregnancy Childbirth
– Research on physical activity interventions by Russo LM, Nobles C, and others in 2015
– Findings on the effectiveness of physical activity interventions by Sanabria-Martínez G and colleagues in 2015
– Maternal nutrition research by Silva-Zolezzi I, Samuel TM, and Spieldenner J in 2017
– A healthy lifestyle program for gestational weight gain by Petrella E, Malavolti M, and Bertarini V in 2014
– A study on lifestyle intervention to prevent gestational diabetes by Koivusalo SB, Rono K, Klemetti MM, and others in 2016
– Risk assessment for gestational diabetes mellitus by The Fetal Medicine Foundation
– Guidelines on the management of diabetes in pregnancy by the American Diabetes Association in 2021
– An overview of gestational diabetes mellitus by McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, and Damm P in 2019.